US6656480B2
(en)
*
|
1996-01-11 |
2003-12-02 |
Corixa Corporation |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US7241876B2
(en)
|
1996-01-11 |
2007-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
WO2000075327A1
(fr)
*
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methodes et compositions d'inhibition de croissance cellulaire neoplasique
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6613872B1
(en)
|
1997-02-25 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
EP1005546A2
(fr)
|
1997-02-25 |
2000-06-07 |
Corixa Corporation |
Composes permettant l'immunotherapie du cancer de la prostate et procedes concernant leur utilisation
|
US20030054987A1
(en)
|
1997-06-16 |
2003-03-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
WO1999040189A2
(fr)
*
|
1998-02-09 |
1999-08-12 |
Genset |
ADNc CODANT DES PROTEINES SECRETEES
|
AU2003262114B8
(en)
*
|
1998-02-09 |
2006-08-03 |
Serono Genetics Institute S.A. |
cDNAs encoding secreted proteins
|
US6737514B1
(en)
|
1998-12-22 |
2004-05-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6660838B1
(en)
|
1998-03-18 |
2003-12-09 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US7049063B2
(en)
|
1998-03-18 |
2006-05-23 |
Corixa Corporation |
Methods for diagnosis of lung cancer
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
GB9807723D0
(en)
*
|
1998-04-08 |
1998-06-10 |
Smithkline Beecham Plc |
Novel compounds
|
DE19818620A1
(de)
*
|
1998-04-21 |
1999-10-28 |
Metagen Gesellschaft Fuer Genomforschung Mbh |
Menschliche Nukleinsäuresequenzen aus Blase-Normal
|
US20030036114A1
(en)
|
1998-05-15 |
2003-02-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1999060121A1
(fr)
*
|
1998-05-19 |
1999-11-25 |
Compugen Ltd. |
PROTEINE DU TYPE RECEPTEUR DE GLUTAMATE METABOTROPIQUE ET ADNc DE CODAGE
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
DK1086223T3
(da)
|
1998-06-01 |
2009-11-30 |
Agensys Inc |
Nye serpentintransmembranantigener udtrykt i humane cancerformer og anvendelser deraf
|
AU761340B2
(en)
*
|
1998-06-02 |
2003-06-05 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
WO2000014226A1
(fr)
*
|
1998-09-03 |
2000-03-16 |
Takeda Chemical Industries, Ltd. |
Nouvelle proteine et son procede de production
|
WO2000015793A2
(fr)
*
|
1998-09-17 |
2000-03-23 |
Incyte Pharmaceuticals, Inc. |
Proteines gpcr humaines
|
EP1626058B1
(fr)
*
|
1999-03-08 |
2007-10-31 |
Genentech, Inc. |
Compositions et méthodes pour le diagnostique de tumeurs
|
AU764092B2
(en)
|
1999-03-23 |
2003-08-07 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7244827B2
(en)
|
2000-04-12 |
2007-07-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
EP1792989A1
(fr)
*
|
1999-04-12 |
2007-06-06 |
Agensys, Inc. |
Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
|
AU780061B2
(en)
*
|
1999-04-12 |
2005-02-24 |
Agensys, Inc. |
Transmembrane protein expressed in prostate and other cancers
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
AU3774300A
(en)
*
|
1999-06-02 |
2000-12-18 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU5458300A
(en)
*
|
1999-06-07 |
2000-12-28 |
Human Genome Sciences, Inc. |
26 human secreted proteins
|
US7033780B1
(en)
|
1999-06-14 |
2006-04-25 |
Millennium Pharmaceuticals, Inc. |
Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like protein
|
US20030022279A1
(en)
|
1999-06-14 |
2003-01-30 |
Fraser Christopher C. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
EP1194545A2
(fr)
*
|
1999-06-23 |
2002-04-10 |
Curagen Corporation |
Polypeptides secretes et polynucleotides correspondants
|
US6951738B2
(en)
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
AU780060B2
(en)
*
|
1999-07-16 |
2005-02-24 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
WO2001010902A2
(fr)
*
|
1999-08-11 |
2001-02-15 |
Curagen Corporation |
Polynucleotides et polypeptides codes par ces derniers
|
JP2003531571A
(ja)
*
|
1999-09-13 |
2003-10-28 |
キュラジェン コーポレイション |
新規なヒトタンパク質、それをコードするポリヌクレオチド、およびそれらを使用する方法
|
DK2003202T3
(da)
*
|
1999-10-05 |
2012-01-16 |
Agensys Inc |
G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US7208280B2
(en)
|
1999-10-05 |
2007-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US6835822B1
(en)
|
1999-10-28 |
2004-12-28 |
Agensys, Inc. |
Diagnosis and therapy of cancer using SGP28-related molecules
|
EP1598671A1
(fr)
*
|
1999-10-28 |
2005-11-23 |
Agensys, Inc. |
Diagnotic et traitement du cancer par des molecules apparentées à SGP28
|
FR2800388A1
(fr)
*
|
1999-10-29 |
2001-05-04 |
Pf Medicament |
Clonage, expression et caracterisation d'un gene exprime dans des cellules tumorales et implique dans la regulation de la reponse immune
|
AU1608201A
(en)
*
|
1999-11-16 |
2001-05-30 |
Zymogenetics Inc. |
Human zven proteins
|
US6485938B1
(en)
|
1999-11-16 |
2002-11-26 |
Zymogenetics, Inc. |
Nucleic acid molecules that encodes human Zven1
|
US20020048777A1
(en)
|
1999-12-06 |
2002-04-25 |
Shujath Ali |
Method of diagnosing monitoring, staging, imaging and treating prostate cancer
|
US20020037513A1
(en)
*
|
2000-03-24 |
2002-03-28 |
Rosana Kapeller-Libermann |
33338, a novel human ubiquitin hydrolase-like molecule and uses thereof
|
KR100904593B1
(ko)
*
|
2000-06-23 |
2009-06-25 |
제넨테크, 인크. |
Eg-vegf 핵산 및 폴리펩티드 및 사용 방법
|
EP1302542B1
(fr)
|
2000-07-18 |
2007-06-13 |
Takeda Pharmaceutical Company Limited |
Nouveau peptide actif sur le plan physiologique et utilisation associee
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
WO2002062996A1
(fr)
*
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Nouveau peptide physiologiquement actif et utilisation de ce peptide
|
AUPR311601A0
(en)
*
|
2001-02-15 |
2001-03-08 |
Adp Pharmaceutical Pty Limited |
Matrix gene expression in chondrogenesis
|
US7070584B2
(en)
|
2001-02-20 |
2006-07-04 |
Kci Licensing, Inc. |
Biocompatible wound dressing
|
US7927597B2
(en)
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
JP2005505271A
(ja)
|
2001-09-06 |
2005-02-24 |
アジェンシス, インコーポレイテッド |
癌の処置および検出において有用なsteap−1と名称が与えられる核酸および対応するタンパク質
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
US20040081653A1
(en)
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
CA2500962A1
(fr)
|
2002-10-07 |
2004-04-15 |
Zymogenetics, Inc. |
Utilisations de proteines zven d'origine humaine et polynucleotides associes
|
CA2503346C
(fr)
*
|
2002-11-27 |
2014-03-18 |
Agensys, Inc. |
Acide nucleique 24p4c12 et proteine correspondante utilises dans le traitement et la detection du cancer
|
CN104001158A
(zh)
|
2003-03-12 |
2014-08-27 |
健泰科生物技术公司 |
Bv8和/或EG-VEGF促进造血的用途
|
BRPI0418766B8
(pt)
|
2004-04-22 |
2021-05-25 |
Agensys Inc |
anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
|
FR2982860B1
(fr)
*
|
2011-11-18 |
2015-07-10 |
Ass Fr Contre Les Myopathies |
Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
|
GB201511792D0
(en)
*
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
SG10202001668PA
(en)
|
2015-07-06 |
2020-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
|
PE20200010A1
(es)
|
2017-04-03 |
2020-01-06 |
Hoffmann La Roche |
Anticuerpos que se unen a steap-1
|